Insider trades
Dror Bashan, CEO of Protalix BioTherapeutics PLX, has filed 3 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $101.4K. The latest trade was on 25/12/19.
Dror Bashan
President and CEO
- Company
- Protalix BioTherapeutics PLX
- First filing
- 23/08/17
- Trades
- 7 trades
- Buys / sales
- 3 / 0
- 12-month net buying
- $101.4K
- Last trade
- 25/12/19
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 25/12/19 | 25/12/23 | 56,000 sh | $1.81 | $101,360 | +42.3% | |
PLX | Open-market buy | 23/10/19 | 23/10/20 | 64,516 sh2 trades | $1.40avg. | $90,483.69 | +94.9% |